ConductScience.org, home

Paper33713279

Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions.

van Ophoven A and 3 others. Adv Ther, 2021. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions. Papers, record 33713279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33713279

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions.
PubMed
Journal
Adv Ther
PubMed
Year
2021
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
7.48
iCite
Revised in PubMed
2021-09-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Ophoven AArndt
2Engelberg SStefan
3Lilley HHelen
4Sievert KDKarl-Dietrich

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Electric Stimulation TherapyMajor topic
Urinary Bladder, OveractiveMajor topic
Humans
Lumbosacral Plexus
Retrospective Studies
Treatment Outcome

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in34469676
Editorial Comment: Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dys-function (nLUTD): Over 20 Years' Experience and Fu-ture Directions.
https://conductscience.org/library/papers/34469676

Source PubMed

Download CSV of comments and corrections

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118542773Early versus late treatment of voiding dysfunction with pelvic neuromodulation.Can Urol Assoc J2007https://conductscience.org/library/papers/18542773PubMed
228709886Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.J Urol2018https://conductscience.org/library/papers/28709886PubMed
318499185Detrusor acontractility in urinary retention: detrusor contractility test as exclusion criteria for sacral neurostimulation.J Urol2008https://conductscience.org/library/papers/18499185PubMed
430794909Abdominal Versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator.Urology2019https://conductscience.org/library/papers/30794909PubMed
525546568Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.Neurourol Urodyn2016https://conductscience.org/library/papers/25546568PubMed
621689330Sacral nerve stimulation for faecal incontinence: patient selection, service provision and operative technique.Colorectal Dis2011https://conductscience.org/library/papers/21689330PubMed
72787411Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders.J Urol1989https://conductscience.org/library/papers/2787411PubMed
825123172Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction.BMC Urol2014https://conductscience.org/library/papers/25123172PubMed
927106070More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.Eur Urol2016https://conductscience.org/library/papers/27106070PubMed
1016230129Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure?Urology2005https://conductscience.org/library/papers/16230129PubMed
1127676460The impact of prior back surgery on neuromodulation outcomes: A review of over 500 patients.Neurourol Urodyn2017https://conductscience.org/library/papers/27676460PubMed
1220934242Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis.Eur Urol2010https://conductscience.org/library/papers/20934242PubMed
1311976011Imaging in chronic spinal cord injury--indications and benefits.Eur J Radiol2002https://conductscience.org/library/papers/11976011PubMed
1419238164Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms.Spinal Cord2009https://conductscience.org/library/papers/19238164PubMed
1523537757Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.Urology2013https://conductscience.org/library/papers/23537757PubMed
1614532804New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.J Urol2003https://conductscience.org/library/papers/14532804PubMed
1722151195Findings with Bilateral Sacral Neurostimulation: Sixty-two PNE-Tests in Patients with Neurogenic and Idiopathic Bladder Dysfunctions.Neuromodulation2004https://conductscience.org/library/papers/22151195PubMed
1830864008Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents.World J Urol2019https://conductscience.org/library/papers/30864008PubMed
1932019718Sacral Neuromodulation: Mechanism of Action.Eur Urol Focus2020https://conductscience.org/library/papers/32019718PubMed
2028607577MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.Ther Adv Neurol Disord2017https://conductscience.org/library/papers/28607577PubMed

See all 70 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
42961549Research hotspots and dynamic trends in sacral neuromodulation for pelvic floor dysfunction: a comprehensive bibliometric analysis.Updates Surg2026https://conductscience.org/library/papers/42961549PubMed
42733748Electrical Pudendal Nerve Stimulation as an Initial Neuromodulation Strategy for Neurogenic Urinary Retention.Eur Urol Open Sci2026https://conductscience.org/library/papers/42733748PubMed
42687596Feasibility and preliminary outcomes of spinal magnetic stimulation for functional constipation: a pilot randomized placebo-controlled trial.Ann Coloproctol2026https://conductscience.org/library/papers/42687596PubMed
42554753Neuromodulation for Lower Urinary Tract Dysfunction: Mechanisms, Modalities, and Patient Selection.Int Urogynecol J2026https://conductscience.org/library/papers/42554753PubMed
42452600Neurogenic Pelvic Floor Dysfunctions Across Neurological Disorders: Mechanisms, Phenotypes, and Precision Rehabilitation Pathways-A Narrative Review.J Clin Med2026https://conductscience.org/library/papers/42452600PubMed
42240894Fifteen years of intrathecal baclofen therapy in China: complications, safety governance, and a multimodal neuromodulation strategy.Acta Neurochir (Wien)2026https://conductscience.org/library/papers/42240894PubMed
41404536Update on the Treatment of Autonomic Disorders.Curr Treat Options Neurol2025https://conductscience.org/library/papers/41404536PubMed
41251120Should We Consider Sacral Nerve Stimulation as a Treatment for Neurogenic Lower Urinary Tract Dysfunction? ICI-RS 2025.Neurourol Urodyn2026https://conductscience.org/library/papers/41251120PubMed
41146782Sacral Neuromodulator Surgery: Is There an Ideal Candidate?Cureus2025https://conductscience.org/library/papers/41146782PubMed
41123027Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta-Analysis.Neurourol Urodyn2026https://conductscience.org/library/papers/41123027PubMed
40956334Advancing women's health: innovative applications of sacral neuromodulation in pelvic floor dysfunctions.Arch Gynecol Obstet2025https://conductscience.org/library/papers/40956334PubMed
40919823Recent Technological Advances in Monitoring and Neuromodulation of Non-Malignant and Neurogenic Bladder Conditions.Adv Healthc Mater2026https://conductscience.org/library/papers/40919823PubMed
40804625Intraoperative application of different imaging techniques in sacral neuromodulation: a systematic review and meta-analysis.BMC Urol2025https://conductscience.org/library/papers/40804625PubMed
40777094Updates in pelvic neuromodulation: the role of pelvic neuromodulation in pelvic disorders.Front Urol2024https://conductscience.org/library/papers/40777094PubMed
40765533Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction.Curr Urol2025https://conductscience.org/library/papers/40765533PubMed
40681209Effectiveness of electroacupuncture for the treatment of refractory overactive bladder disease in women: study protocol for a randomised controlled clinical trial.BMJ Open2025https://conductscience.org/library/papers/40681209PubMed
40549020Off-Label but On-Target: Sacral Neuromodulation for Neurogenic Bladder Dysfunction.Curr Urol Rep2025https://conductscience.org/library/papers/40549020PubMed
40503868
Overcoming barriers to accessing sacral neuromodulation care in Canada Re: "Urologist-perceived barriers and perspectives on the underuse of sacral neuromodulation for overactive bladder in Canada" (Can Urol Assoc J 2023;17:E165-71).
Can Urol Assoc J2025https://conductscience.org/library/papers/40503868PubMed
40223778Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction in Patients With Multiple Sclerosis: A Pilot Trial.Neurourol Urodyn2025https://conductscience.org/library/papers/40223778PubMed
40211833Outcomes of Sacral Neuromodulation and Intradetrusor Onabotulinum Toxin in the Management of Stroke Associated Urinary Incontinence.Int Neurourol J2025https://conductscience.org/library/papers/40211833PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33713279

GET https://conductscience.org/api/papers/v1/33713279/references?page=2